Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP425636.RAjjsaQpweHPzb6_6RDJ6X5NUWcupebGaE2rNLnfoWPdc130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425636.RAjjsaQpweHPzb6_6RDJ6X5NUWcupebGaE2rNLnfoWPdc130_provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP830312.RADjsoEzWXy3S52Wdw3GLaQmpRWhlcjjWyILE1w1kJxuY130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830312.RADjsoEzWXy3S52Wdw3GLaQmpRWhlcjjWyILE1w1kJxuY130_provenance.
• NP380817.RAyh5sTE_gurlO0PkYI0UVZ-gC_5f5yQqeijzq_Mt93ok130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380817.RAyh5sTE_gurlO0PkYI0UVZ-gC_5f5yQqeijzq_Mt93ok130_provenance.
• NP732439.RADFp85yMpNwwjl9L3rFzW5ZtP3jUCAVgB4LGLOoEA4EI130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732439.RADFp85yMpNwwjl9L3rFzW5ZtP3jUCAVgB4LGLOoEA4EI130_provenance.
• NP732440.RABX_9EIFGRP5K8DzxeIzIxco9CqozIgBLNwWaGtLnTPU130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732440.RABX_9EIFGRP5K8DzxeIzIxco9CqozIgBLNwWaGtLnTPU130_provenance.
• NP732444.RADHAMsaBpD9nhrd7TkYk-_P-leoY8-KSHoNLBDOeOqxw130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732444.RADHAMsaBpD9nhrd7TkYk-_P-leoY8-KSHoNLBDOeOqxw130_provenance.
• NP732445.RAAFAfpfM5us7UWh1v1rSUMXICE6N2sCutyjIT_vgdRg0130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732445.RAAFAfpfM5us7UWh1v1rSUMXICE6N2sCutyjIT_vgdRg0130_provenance.
• NP673600.RAYMxHtYK5Rkr-Eln4NnTlsdfSCQyssoqOr1GlbBArqfw130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673600.RAYMxHtYK5Rkr-Eln4NnTlsdfSCQyssoqOr1GlbBArqfw130_provenance.
• NP727095.RARIK0mr5hIoBMoEcP-ePYi6IuLiZBk5RfFfCxK3tKDB0130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727095.RARIK0mr5hIoBMoEcP-ePYi6IuLiZBk5RfFfCxK3tKDB0130_provenance.
• NP727099.RAZ8sa8dx2In2AzMwFp40eIradChcVU6rS55mw6FbtUU4130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727099.RAZ8sa8dx2In2AzMwFp40eIradChcVU6rS55mw6FbtUU4130_provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP830313.RA-Gz7csG3hqnqkPTSVh17-9imFwoX5IGLO-uEICHziAM130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830313.RA-Gz7csG3hqnqkPTSVh17-9imFwoX5IGLO-uEICHziAM130_provenance.
• NP732442.RA4roa5CX0sGrqjfwYrGA9p3-8qfnFs28i7ffbOZxBMho130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732442.RA4roa5CX0sGrqjfwYrGA9p3-8qfnFs28i7ffbOZxBMho130_provenance.
• NP732446.RA2tnpTA9rpvOE7p6sXdYBu__2H17yskPEhNLSXdEoXaU130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732446.RA2tnpTA9rpvOE7p6sXdYBu__2H17yskPEhNLSXdEoXaU130_provenance.
• NP732443.RARs3mLwflUzYpACXi1dFh6CwIZu211EHcV0uirfS0e-Y130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732443.RARs3mLwflUzYpACXi1dFh6CwIZu211EHcV0uirfS0e-Y130_provenance.
• NP756232.RAP2oEFhcIOEtY0hjxtXfq-_C9l36dQKutQpn3Rnl6a90130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756232.RAP2oEFhcIOEtY0hjxtXfq-_C9l36dQKutQpn3Rnl6a90130_provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP732441.RAGCxtFtqCzfaJSlhrH62mdXIIznxnvhWRkvnbPEm8Gf8130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732441.RAGCxtFtqCzfaJSlhrH62mdXIIznxnvhWRkvnbPEm8Gf8130_provenance.
• NP239598.RAlSBAdvbxmDwe6XeDyuu_0_SnGRw98OLyBA_k5AiWtXc130_assertion description "[Three proteins were uniquely altered in vaginal carcinoma (DDX48, erbB3-binding protein and biliverdin reductase) and five in cervical carcinoma (peroxiredoxin 2, annexin A2, sarcomeric tropomyosin kappa, human ribonuclease inhibitor and prolyl-4-hydrolase beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239598.RAlSBAdvbxmDwe6XeDyuu_0_SnGRw98OLyBA_k5AiWtXc130_provenance.